XORTX Therapeutics Inc. (NASDAQ:XRTX – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.20 and traded as high as $2.64. XORTX Therapeutics shares last traded at $2.44, with a volume of 32,581 shares.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XORTX Therapeutics in a research report on Wednesday, June 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Get Our Latest Research Report on XORTX Therapeutics
XORTX Therapeutics Price Performance
XORTX Therapeutics (NASDAQ:XRTX – Get Free Report) last issued its quarterly earnings data on Saturday, August 15th. The technology company reported ($1.05) EPS for the quarter.
Institutional Investors Weigh In On XORTX Therapeutics
A hedge fund recently raised its position in XORTX Therapeutics stock. Citadel Advisors LLC boosted its position in XORTX Therapeutics Inc. (NASDAQ:XRTX – Free Report) by 124.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 86,326 shares of the technology company’s stock after purchasing an additional 47,858 shares during the period. Citadel Advisors LLC owned 1.24% of XORTX Therapeutics worth $70,000 at the end of the most recent quarter. Institutional investors and hedge funds own 0.23% of the company’s stock.
XORTX Therapeutics Company Profile
Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.
Featured Stories
- Five stocks we like better than XORTX Therapeutics
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
